Oxford/AstraZeneca Vaccine Shows 70% Efficacy As Company Prepares Approval Filings
Vaccine Will Be 'Affordable And Globally Available'
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
